Skip to main content
. 2020 Jun 13;2020:2139192. doi: 10.1155/2020/2139192

Figure 5.

Figure 5

Treatment with oAβ induces differentiated SH-SY5Y neuronal apoptosis only in the presence of microglia, acting through Fpr2/3-sensitive ROS release. (a) Treatment with oAβ (100 nM, 48 hrs) had no effect on trans-retinoic acid- (tRA-) differentiated SH-SY5Y cell viability; data are mean ± SEM of 5 independent cultures, assayed in triplicate. (b) Separation of tRA-differentiated SH-SY5Y neurons from BV2 cells grown in coculture on the basis of differential CD200 and CD11b expression; plot is representative of 3 independent cultures. (c) Treatment of cocultures of BV2 and tRA-differentiated SH-SY5Y neurons with oAβ (100 nM, 48 hrs) induces significant SH-SY5Y apoptosis, an effect prevented by subsequent treatment with QC1 (100 nM, 10 min post-oAβ). (d) Conditioned medium from BV2 cells treated or not with 100 nM oAβ (24 hrs) had no effect on tRA-differentiated SH-SY5Y neuronal apoptosis following exposure for 48 hrs. (e) Inclusion of the antioxidant α-tocopherol (10 μM) in cocultures of BV2 cells and tRA-differentiated SH-SY5Y neurons prevented oAβ-induced (100 nM, 48 hrs) neuronal apoptosis; data are mean ± SEM for 3-6 independent cultures, assayed in triplicate, ∗p < 0.05.